Isocaine

Isocaine

Isocaine Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

RESUSCITATIVE EQUIPMENT AND DRUGS SHOULD BE IMMEDIATELY AVAILABLE. (See ADVERSE REACTIONS).

Reactions resulting in fatality have occurred on rare occasions with the use of local anesthetics, even in the absence of a history of hyper- sensitivity.

Fatalities may occur with use of local anesthetics in the head and neck region as the result of retrograde arterial flow to vital CNS areas even when maximum recommended doses are observed. The practitioner should be alert to early evidence of alteration in sensorium or vital signs.

The solution which contains a vasoconstrictor should be used with extreme caution for patients whose medical history and physical evaluation suggest the existence of hypertension, arteriosclerotic heart disease, cerebral vascular insufficiency, heart block, thyrotoxicosis and diabetes, etc.

Isocaine 2% with Levonordefrin 1:20,000 injection (Mepivacaine Hydrochloride and Levonordefrin Injection, USP) contains sodium bisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people. Isocaine 3% injection (Mepivacaine Hydrochloride Injection USP 3%) is SULFITE FREE.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

ISOCAINE is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients.

History

There is currently no drug history available for this drug.

Other Information

ISOCAINE (Mepivacaine Hydrochloride), a tertiary amine used as a local anesthetic, is 1-methyl-2', 6' - pipecoloxylidide monohydrochloride with the following structural formula:

Image from Drug Label Content

It is a white, crystalline, odorless powder soluble in water, but very resistant to both acid and alkaline hydrolysis.

Levonordefrin, a sympathomimetic amine used as a vasoconstrictor in local anesthetic solution, is (-)-a-(1-Aminoethyl)-3, 4-dihydroxybenzyl alcohol with the following structural formula:

Image from Drug Label Content

It is a white or buff-colored crystalline solid, freely soluble in aqueous solutions of mineral acids, but practically insoluble in water.

DENTAL CARTRIDGES MAY NOT BE AUTOCLAVED.

ISOCAINE 3% Injection and ISOCAINE 2% with Levonordefrin 1:20,000 Injection are sterile solutions for injection.

COMPOSITION CARTRIDGE
Each mL contains: 2% 3%
  Mepivacaine Hydrochloride 20 mg 30 mg
  Levonordefrin (as the base) 0.05 mg -
  Sodium Chloride 4 mg 3 mg
  Sodium Bisulfite 1 mg -
  Water For Injection, qs. ad. 1 mL 1 mL
  The pH of the 2% cartridge solution is adjusted between 3.3 and 5.5 with NaOH or HCI.
  The pH of the 3% cartridge solution is adjusted between 4.5 and 6.8 with NaOH or HCI.

Isocaine Manufacturers


  • Septodont Inc
    Isocaine (Mepivacaine Hydrochloride) Injection, Solution Isocaine With Levonordefrin (Mepivcaine Hydrochloride And Levonordefrin) Injection, Solution [Septodont Inc]

Login To Your Free Account